1. Home
  2. BGM vs PASG Comparison

BGM vs PASG Comparison

Compare BGM & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGM
  • PASG
  • Stock Information
  • Founded
  • BGM 2019
  • PASG 2017
  • Country
  • BGM China
  • PASG United States
  • Employees
  • BGM N/A
  • PASG N/A
  • Industry
  • BGM
  • PASG Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGM
  • PASG Health Care
  • Exchange
  • BGM NYSE
  • PASG Nasdaq
  • Market Cap
  • BGM 309.0M
  • PASG 42.2M
  • IPO Year
  • BGM 2021
  • PASG 2020
  • Fundamental
  • Price
  • BGM $9.20
  • PASG $0.60
  • Analyst Decision
  • BGM
  • PASG Strong Buy
  • Analyst Count
  • BGM 0
  • PASG 3
  • Target Price
  • BGM N/A
  • PASG $8.00
  • AVG Volume (30 Days)
  • BGM 32.9K
  • PASG 894.5K
  • Earning Date
  • BGM 02-13-2025
  • PASG 03-03-2025
  • Dividend Yield
  • BGM N/A
  • PASG N/A
  • EPS Growth
  • BGM N/A
  • PASG N/A
  • EPS
  • BGM N/A
  • PASG N/A
  • Revenue
  • BGM N/A
  • PASG N/A
  • Revenue This Year
  • BGM N/A
  • PASG N/A
  • Revenue Next Year
  • BGM N/A
  • PASG N/A
  • P/E Ratio
  • BGM N/A
  • PASG N/A
  • Revenue Growth
  • BGM N/A
  • PASG N/A
  • 52 Week Low
  • BGM $1.78
  • PASG $0.45
  • 52 Week High
  • BGM $14.78
  • PASG $1.79
  • Technical
  • Relative Strength Index (RSI)
  • BGM 48.61
  • PASG 43.09
  • Support Level
  • BGM $8.80
  • PASG $0.61
  • Resistance Level
  • BGM $14.78
  • PASG $1.01
  • Average True Range (ATR)
  • BGM 1.04
  • PASG 0.10
  • MACD
  • BGM 0.05
  • PASG -0.01
  • Stochastic Oscillator
  • BGM 14.94
  • PASG 6.77

About BGM QILIAN INTERNATIONAL HLDG GROUP LTD

BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Share on Social Networks: